NCT07470008 Prospective Registry of Histotripsy for Soft Tissue Tumors
| NCT ID | NCT07470008 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Soft Tissue Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-01-29 |
| Primary Completion | 2030-08-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2026-01-29 with a primary completion date of 2030-08-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.
Eligibility Criteria
Inclusion Criteria: * All adult patients who are treated with histotripsy per standard clinical care at University of California San Francisco (UCSF) are eligible for inclusion in the registry. Exclusion Criteria: * Children/minors, and adults who lack decision-making capacity, will be excluded from the registry. Patients who do not consent for inclusion in the registry will also be excluded.
Contact & Investigator
Ryan Lokken, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT07470008 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Soft Tissue Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07470008 currently recruiting?
Yes, NCT07470008 is actively recruiting participants. Contact the research team at cancertrials@ucsf.edu for enrollment information.
Where is the NCT07470008 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT07470008 clinical trial?
NCT07470008 is sponsored by University of California, San Francisco. The principal investigator is Ryan Lokken, MD at University of California, San Francisco. The trial plans to enroll 200 participants.